Paper322205
Cellular responses to combinations of hyperthermia and radiation.
Dewey WC and 3 others. Radiology, 1977. Cited by 748 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cellular responses to combinations of hyperthermia and radiation. Papers, record 322205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/322205
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperthermia, Induced | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Body Temperature | |
| Cell Division | |
| Cell Movement | |
| Chromosomal Proteins, Non-Histone | |
| Hypoxia | |
| Mathematics | |
| Oxygen Consumption | |
| Protein Denaturation | |
| Time Factors | |
| X-Ray Therapy |
Source PubMed
Cited by114
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 748 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42618455 | Design, verification and validation of a spatially confined magnetic nanoparticle thermal therapy device for conformal thermal dose contouring. | Int J Hyperthermia | 2026 | https://conductscience.org/library/papers/42618455 | PubMed |
| 42420717 | Mathematical Descriptions of Damage to Cells and Tissues Following Heating. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42420717 | PubMed |
| 42101619 | Capacitive heating devices for therapeutic hyperthermia: a review of essential physical characteristics and challenges. | Strahlenther Onkol | 2026 | https://conductscience.org/library/papers/42101619 | PubMed |
| 41445170 | Radio Frequency Exposure in Military Contexts: A Narrative Review of Thermal Effects and Safety Considerations. | Mil Med | 2026 | https://conductscience.org/library/papers/41445170 | PubMed |
| 41025872 | Exploring the Interplay Between Hyperthermia and Cytotoxic Drugs in Ocular Melanoma Cell Lines: Implications and Variability in Treatment Efficiency. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/41025872 | PubMed |
| 40761767 | Magnetic resonance thermometry in the target volume versus intraluminal probe thermometry for hyperthermia treatment monitoring. | Phys Imaging Radiat Oncol | 2025 | https://conductscience.org/library/papers/40761767 | PubMed |
| 40528174 | Photothermal Hyperthermia Suppresses Liver Tumor Growth Via Hippo Signaling Pathway-Dependent Inhibition of Cell Proliferation and Induction of Apoptosis. | Biol Proced Online | 2025 | https://conductscience.org/library/papers/40528174 | PubMed |
| 39682105 | The Rationale for Combining Hypofractionated Radiation and Hyperthermia. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682105 | PubMed |
| 38539491 | Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment-The Current State of Knowledge. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38539491 | PubMed |
| 37312933 | Cu3P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/37312933 | PubMed |
| 37242631 | Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast Cancer. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37242631 | PubMed |
| 37216091 | Heat promotes melanogenesis by increasing the paracrine effects in keratinocytes via the TRPV3/Ca2+/Hh signaling pathway. | iScience | 2023 | https://conductscience.org/library/papers/37216091 | PubMed |
| 37177718 | Design and Validation of Experimental Setup for Cell Spheroid Radiofrequency-Induced Heating. | Sensors (Basel) | 2023 | https://conductscience.org/library/papers/37177718 | PubMed |
| 37102792 | Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability-an in-silico study. | Br J Radiol | 2023 | https://conductscience.org/library/papers/37102792 | PubMed |
| 37040569 | Magnetic Control of Protein Expression via Magneto-mechanical Actuation of ND-PEGylated Iron Oxide Nanocubes for Cell Therapy. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/37040569 | PubMed |
| 36839948 | Role of HIKESHI on Hyperthermia for Castration-Resistant Prostate Cancer and Application of a Novel Magnetic Nanoparticle with Carbon Nanohorn for Magnetic Hyperthermia. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839948 | PubMed |
| 36230717 | Avoiding Pitfalls in Thermal Dose Effect Relationship Studies: A Review and Guide Forward. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230717 | PubMed |
| 36004885 | Simultaneous Maturation of Single Chain Antibody Stability and Affinity by CHO Cell Display. | Bioengineering (Basel) | 2022 | https://conductscience.org/library/papers/36004885 | PubMed |
| 35678795 | Cellular and Molecular Mechanism of Cell Proliferation in Human Gastric Cancer Drug-Resistant Cells After Hyperthermia and Cisplatin: Role of mRNAs and Long-Non-coding RNAs. | Turk J Gastroenterol | 2022 | https://conductscience.org/library/papers/35678795 | PubMed |
| 35519668 | Magnetically responsive polycaprolactone nanocarriers for application in the biomedical field: magnetic hyperthermia, magnetic resonance imaging, and magnetic drug delivery. | RSC Adv | 2020 | https://conductscience.org/library/papers/35519668 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/322205
GET https://conductscience.org/api/papers/v1/322205/cited_by?page=2